FDA Inspection
Catalent Germany Eberbach GmbHCatalent Germany Eberbach GmbH – FDA Inspection, Feb 2, 2024
Record Details
This FDA Inspection record concerns Catalent Germany Eberbach GmbH, with an inspection on February 2, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 2, 2024
- Product Type
- Drugs
View Company Profile
ID · 5a4da443-351c-4f3b-8bd1-0c11e78876e7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1255823
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Catalent Germany Eberbach GmbH
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2013 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
Other documents for Catalent Germany Eberbach GmbH
- FDA Inspection 1106613 - 2019-09-06
- FDA Inspection 1048712 - 2018-03-02
- FDA Inspection 989834 - 2016-03-18
- FDA Inspection 850147 - 2013-09-12
- FDA Inspection 818378 - 2013-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.